Stevanato Group Q1 2025 Earnings Report
Key Takeaways
Stevanato Group reported a 9% increase in revenue for the first quarter of 2025, reaching €256.6 million, primarily driven by strong performance in the Biopharmaceutical and Diagnostic Solutions segment. Gross profit and operating profit margins also improved. The company maintained its full-year revenue guidance but lowered its adjusted EBITDA and adjusted diluted EPS guidance to reflect the estimated impact of recently announced tariffs.
Revenue increased by 9% to €256.6 million in Q1 2025 compared to the prior year.
The Biopharmaceutical and Diagnostic Solutions segment saw 11% revenue growth, offsetting a decline in the Engineering segment.
Gross profit margin improved by 80 basis points to 27.2%, and adjusted operating profit margin increased to 14.3%.
Full-year 2025 guidance for adjusted EBITDA and adjusted diluted EPS was updated to reflect the estimated impact of tariffs.
Stevanato Group
Stevanato Group
Stevanato Group Revenue by Segment
Forward Guidance
For fiscal year 2025, Stevanato Group maintains its revenue guidance of €1,160 million to €1,190 million. However, guidance for adjusted EBITDA is updated to €288.5 million to €301.8 million, and adjusted diluted EPS to €0.50 to €0.54, reflecting an estimated €4.5 million tariff impact on operating profit.
Positive Outlook
- Maintaining full-year revenue guidance (€1,160 million - €1,190 million).
- Continued strong demand for high-value solutions expected.
- Expected continued improvements and scaling at Latina and Fishers facilities.
- Gradual stabilization expected in vial demand as destocking fades.
- Business fundamentals are strong with favorable secular tailwinds.
Challenges Ahead
- Lowering adjusted EBITDA guidance (€288.5 million - €301.8 million) due to estimated tariffs.
- Lowering adjusted diluted EPS guidance (€0.50 - €0.54) due to estimated tariffs.
- Estimated tariff impact of approximately €4.5 million on operating profit.
- Ongoing focus on completing legacy projects in the Engineering segment.
- Anticipating absorption of price increases from suppliers due to tariffs.
Revenue & Expenses
Visualization of income flow from segment revenue to net income